Research Focus

Former Employee. Medicine; Research Stdy Asst II

Recent additions – View all

1. Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis

   Meeting Abstract

   Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
   Journal of Clinical Oncology (2018)

   Fulltext@MSK | Save
2. A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis

   Meeting Abstract

   Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
   Annals of Oncology (2018)

   Fulltext@MSK | Save
3. Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Phase I results

   Journal Article

   O’Reilly, E. M.; Roach, J.; Miller, P.; Yu, K. H.; Tjan, C.; Rosano, M.; Krause, S.; Avery, W.; Wolf, J.; Flaherty, K.; more...
   The Oncologist (2017)

   Fulltext@MSK | Save